000 01488 a2200361 4500
005 20250517100219.0
264 0 _c20170303
008 201703s 0 0 eng d
022 _a1873-3441
024 7 _a10.1016/j.ejpb.2016.05.021
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBala, Vaskor
245 0 0 _aFacilitating gastrointestinal solubilisation and enhanced oral absorption of SN38 using a molecularly complexed silica-lipid hybrid delivery system.
_h[electronic resource]
260 _bEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
_cAug 2016
300 _a32-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAnimals
650 0 4 _aBiological Availability
650 0 4 _aCamptothecin
_xadministration & dosage
650 0 4 _aDrug Delivery Systems
650 0 4 _aFemale
650 0 4 _aGastrointestinal Tract
_xmetabolism
650 0 4 _aIrinotecan
650 0 4 _aLipids
_xchemistry
650 0 4 _aRats
650 0 4 _aSilicon Dioxide
_xchemistry
650 0 4 _aSolubility
700 1 _aRao, Shasha
700 1 _aPrestidge, Clive A
773 0 _tEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
_gvol. 105
_gp. 32-9
856 4 0 _uhttps://doi.org/10.1016/j.ejpb.2016.05.021
_zAvailable from publisher's website
999 _c26076730
_d26076730